Lancet Infectious Diseases Submission Process

The Lancet Infectious Diseases is not looking for routine observational competence. The best fit is a study that changes clinical behavior, outbreak understanding, antimicrobial strategy, or public-health decision-making. If the paper is solid but locally bounded, another infectious-disease journal may be the better call.

Before submission, make sure these are already aligned:

• manuscript
• cover letter
• abstract and highlights
• figure order
• reporting checklist
• ethics and disclosure statements
• language around equity, access, or implementation when relevant

This journal notices quickly when a paper is trying to claim policy or practice significance without a correspondingly solid package.

The upload step is mostly about consistency. Every surface in the package should describe the same study and the same level of confidence. If the abstract sounds decisive, but the manuscript reveals major limitations or local constraints that were hidden early, that mismatch works against you.

Before review, the editor is often asking:

• is this question important now
• does the paper matter beyond one hospital or one outbreak snapshot
• are the methods strong enough for high-level infectious-disease review
• do the results actually change a clinical or public-health decision

That is the real first decision gate. Timeliness and relevance matter as much as technical competence here.

The journal wants to know what changes in clinical care, surveillance, policy, or preparedness if this paper is true.

High-consequence infectious-disease claims attract careful scrutiny. Weak comparative design, underpowered cohorts, or unstable inference are hard to hide.

Many infectious-disease studies are important locally. This journal is testing whether the lesson travels more broadly.

If the work feels late, partial, or underframed, editorial enthusiasm drops quickly.

A strong package usually shows:

• a question that matters beyond one local setting
• clean methods and appropriately bounded claims
• clear clinical or public-health consequence
• figures that surface the main result quickly
• writing that does not confuse urgency with proof

The paper should feel like a consequential infectious-disease article, not a strong local report dressed up for a larger stage.

The first stall point is scope. Authors often have a real infectious-disease signal, but the paper is still too local or too narrow in implication. The second is timing. A study can be scientifically competent but miss the journal if the window of broader urgency has already passed. The third is overclaiming. Editors are especially sensitive when the abstract promises policy or treatment consequences that the evidence only partly supports.

The cover letter should help the editor understand consequence and fit quickly. The best version usually:

• states the infectious-disease problem in a way that immediately signals scale
• explains why the result matters beyond one institution or one outbreak setting
• shows why the paper belongs in Lancet Infectious Diseases rather than a narrower specialty journal
• avoids trying to create urgency through rhetoric alone

That tone matters. Editors trust packages that sound disciplined more than ones that sound breathless.

Before submission, assume reviewers will ask some version of:

• is the policy or treatment consequence really this large
• does the dataset justify a global conclusion
• are access, equity, or implementation issues being ignored
• is the paper late relative to the urgency it claims

If the manuscript answers those questions on its own, it has a better chance of surviving both editorial triage and review.

Run one last editorial test:

• does the abstract make the consequence clear without overclaiming
• would an editor believe the findings matter outside one local setting
• do the figures support the most policy- or treatment-relevant conclusion
• are implementation or access questions addressed where they obviously matter
• if the urgency disappeared tomorrow, would the paper still feel important

That check separates durable significance from a merely timely frame.

Try explaining the study to an infectious-disease editor in one sentence. If the value only sounds important once you add urgency, institutional prestige, or lots of context, the paper may still be too narrow. If the implication sounds important even after you strip away rhetorical pressure, the package is much closer to ready.

The strongest packages usually avoid three visible problems:

• local framing that never becomes globally relevant
• outbreak or surveillance urgency that is being used to cover weak inference
• implementation claims that sound larger than the evidence base

If those problems are already edited out before upload, the package tends to read as much more stable and much more publishable.

In our pre-submission review work with manuscripts targeting Lancet Infectious Diseases, five patterns generate the most consistent desk rejections worth knowing before submission.

Local findings framed as globally relevant without adequate support (roughly 35%). The Lancet Infectious Diseases information for authors requires that submitted work demonstrate clinical, public-health, or policy significance beyond a single institution or outbreak context. In our experience, roughly 35% of desk rejections involve papers where the findings are scientifically valid but the scope of clinical or epidemiological impact is local, without evidence that the lessons transfer to other settings or populations. Editors consistently flag this as the primary reason manuscripts fail triage without reaching external review.

Abstract claiming clinical consequences the study data cannot support (roughly 25%). In our experience, roughly 25% of submissions present an abstract asserting practice-changing or policy-relevant significance while the manuscript reveals limitations that constrain those claims substantially. Editors consistently reject manuscripts where the abstract and the methods section describe different levels of certainty, because the mismatch is visible immediately to a Lancet Infectious Diseases triage reader.

Laboratory work without demonstrable clinical or population relevance (roughly 20%). In our experience, roughly 20% of submissions present strong preclinical or mechanistic data without a validated bridge to clinical or population-level outcomes. Editors consistently flag these submissions as mismatched to the journal's editorial scope, which requires demonstrable clinical or public-health consequence rather than biological interest alone.

Reporting checklist incomplete or inconsistent with manuscript claims (roughly 15%). In our experience, roughly 15% of submissions arrive with reporting checklists that are incomplete, inconsistently filled, or in conflict with the methods described in the manuscript. Editors consistently screen for reporting compliance because a gap between the checklist and the manuscript signals underlying methodological problems that would emerge during review.

Urgency of the outbreak framing used to compensate for weak inference (roughly 10%). In our experience, roughly 10% of submissions leverage the timeliness of an emerging outbreak or public-health event as the primary argument for significance, while the underlying data remain underpowered or the causal inference is weak. Editors consistently reject manuscripts where the urgency of the framing is doing work that the evidence cannot do independently.

Before submitting to Lancet Infectious Diseases, a Lancet Infectious Diseases submission readiness check identifies whether your clinical consequence argument, reporting package, and global-relevance framing meet the editorial bar before you commit to the submission.

• Lancet Infectious Diseases submission guide
• Is Lancet Infectious Diseases a good journal?
• How to avoid desk rejection at Lancet Infectious Diseases